Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Cáceres

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Revista De Enfermeria (Barcelona, Spain)|August 2, 2002
[Optimizing pharmacologic therapy for the elderly]M J Norberto, M Martínez, M C Cáceres, et al.
Archives of Psychiatric Nursing|June 10, 2022
Concordance in psychopharmacological treatment before and after first mental health consultationM J Norberto, L Rodríguez-Santos, J Montanero, et al.
The Psychiatric Quarterly|May 23, 2020
Analysis of Consultation Demand in a Mental Health Centre during the Recent Economic RecessionM J Norberto, L Rodríguez-Santos, M C Cáceres, et al.
Current Drug Targets|December 16, 2006
Clinical implications of CYP2D6 genetic polymorphism during treatment with antipsychotic drugsP Dorado, R Berecz, E M Peñas-Lledó, et al.
European Journal of Clinical Pharmacology|June 13, 2008
Relationship between CYP2C8 genotypes and diclofenac 5-hydroxylation in healthy Spanish volunteersP Dorado, I Cavaco, M C Cáceres, et al.
Current Drug Targets|July 24, 2004
The role of cytochrome P450 enzymes in the metabolism of risperidone and its clinical relevance for drug interactionsR Berecz, P Dorado, A De La Rubia, et al.
The Pharmacogenomics Journal|February 28, 2007
Low frequency of CYP2D6 poor metabolizers among schizophrenia patientsA Llerena, P Dorado, E M Peñas-Lledó, et al.
Fundamental & Clinical Pharmacology|July 20, 2007
Increased risk for major depression associated with the short allele of the serotonin transporter promoter region (5-HTTLPR-S) and the CYP2C9*3 alleleP Dorado, E M Peñas-Lledó, A P González, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Revista De Enfermeria (Barcelona, Spain)|August 2, 2002
[Optimizing pharmacologic therapy for the elderly]M J Norberto, M Martínez, M C Cáceres, et al.
Archives of Psychiatric Nursing|June 10, 2022
Concordance in psychopharmacological treatment before and after first mental health consultationM J Norberto, L Rodríguez-Santos, J Montanero, et al.
The Psychiatric Quarterly|May 23, 2020
Analysis of Consultation Demand in a Mental Health Centre during the Recent Economic RecessionM J Norberto, L Rodríguez-Santos, M C Cáceres, et al.
Current Drug Targets|December 16, 2006
Clinical implications of CYP2D6 genetic polymorphism during treatment with antipsychotic drugsP Dorado, R Berecz, E M Peñas-Lledó, et al.
European Journal of Clinical Pharmacology|June 13, 2008
Relationship between CYP2C8 genotypes and diclofenac 5-hydroxylation in healthy Spanish volunteersP Dorado, I Cavaco, M C Cáceres, et al.
Current Drug Targets|July 24, 2004
The role of cytochrome P450 enzymes in the metabolism of risperidone and its clinical relevance for drug interactionsR Berecz, P Dorado, A De La Rubia, et al.
The Pharmacogenomics Journal|February 28, 2007
Low frequency of CYP2D6 poor metabolizers among schizophrenia patientsA Llerena, P Dorado, E M Peñas-Lledó, et al.
Fundamental & Clinical Pharmacology|July 20, 2007
Increased risk for major depression associated with the short allele of the serotonin transporter promoter region (5-HTTLPR-S) and the CYP2C9*3 alleleP Dorado, E M Peñas-Lledó, A P González, et al.
Pageof 1